Guidelines for Adolescent Health Research: A position paper of the Society for Adolescent Medicine

Journal of Adolescent Health

Volumn 33, Issue 5, 2003, Pages 396-409

  Santelli, John S ^a   Rogers, Audrey Smith ^b   Rosenfeld, Walter D ^b   DuRant, Robert H ^b   Dubler, Nancy ^b   Morreale, Madlyn ^b   English, Abigail ^b   Lyss, Sheryl ^b   Wimberly, Yolanda ^b   Schissel, Anna ^b  

^a Society for Adolescent Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CHILD BEHAVIOR; COMMUNITY; ETHICS; FOOD AND DRUG ADMINISTRATION; HEALTH BEHAVIOR; HUMAN; INFORMED CONSENT; LAW; LEGAL ASPECT; MEDICAL RESEARCH; MEDICINE; PARENT; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRIVACY; REVIEW; RISK;

EID: 0242315067     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2003.06.009     Document Type: Article

References (76)

1. Anonymous. Guidelines for Adolescent Health Research. J Adolesc Health 1995;17:264-9.
2. Adolescent Health-Volume I Summary and Policy Options. 1991;U.S. Government Printing Office, Washington, DC. OTA-H-468.
3. National Commission on the Role of the School and the Community in Improving Adolescent Health. Code Blue: Uniting for Healthier Youth. City, state: National Association of State Boards of Education and American Medical Association, 1991.
4. Task Force on Education of Young Adolescents. Turning Points: Preparing American Youth for the 21st Century. Washington, DC: Carnegie Council on Adolescent Development, Carnegie Corporation of New York, 1989.
5. Preventing HIV/AIDS in Adolescents. 1993;National Commission on AIDS, Washington, DC.
6. National Research Council (Miller HG, Turner CF, Moses LE, editors). AIDS: The Second Decade. Washington, DC: National Academy Press, 1990.
7. Moolchan E.T., Mermelstein R. Research on tobacco use among teenagers Ethical challenges. J. Adolesc Health. 30:2002;409-417.
8. Milsap RL, Hill MR, Szefler SJ. Special pharmacokinetic considerations in children. In: Evans WE, Schentag JJ, Jusko WJ (eds). Applied Pharmacokinetics. 3rd edition. Vancouver, WA: Applied Therapeutics, 1992.
9. Rosenfeld W.D., Vermund S.H., Wentz S.J., Burk R.D. High prevalence rate of human papillomavirus infection and association with abnormal smears in sexually active adolescents. Am J Dis Child. 143:1989;1443-1447.
10. Moscicki A.B., Ellenberg J.H., Vermund S.H., et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intra-epithelial lesions in adolescent women Impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med. 154:2000;127-134.
11. Crowley-Nowick P.A., Ellenberg J.H., Vermund S.H., et al. Cytokine profile in genital tract secretions from female adolescents Impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis. 181:2000;939-945.
12. Strobino DM. The health and medical consequences of adolescent sexuality and pregnancy: A review of the literature. In: Hayes CD, Hofferth SL (eds). Risking the Future: Adolescent Sexuality, Pregnancy and Childbearing: Working Papers and Statistical Appendices. Vol. II. Washington, DC: National Academy Press, 1987:888.
13. Korenbrot C.C., Showstack J., Loomis A., Brindis C. Birth weight outcomes with case management in a teenage pregnancy program. J Adolesc Health Care. 10:1989;97-104.
14. Kirby D. Emerging Answers: Research Findings on Programs to Reduce Teen Pregnancy. 2001;The National Campaign to Prevent Teen Pregnancy, Washington, DC.
15. DiClemente R.J. Preventing HIV/AIDS among adolescents. Schools as agents of behavior change. JAMA. 270:1993;760-762.
16. Rogers A.S. A research agenda for the study of therapeutic agents in adolescents. J Adolesc Health. 15:1994;672-678.
17. Elster A.B., Kuznets N.J. AMA Guidelines for Adolescent Preventive Services (GAPS): Recommendations and Rationale. 1993;Williams and Wilkins, Baltimore, MD.
18. Wilson C.M., Houser J., Partlow C., et al. Adolescent Medicine HIV/AIDS Research Network, The REACH Project (Reaching for Excellence in Adolescent Care and Health): Study design, methods, and population profile. J Adolesc Health. 29:(Suppl):2001;8-18.
19. DuRant R.H., Pendergrast R.A., Cadenhead C. Exposure to violence and victimization and fighting behavior by urban black adolescents. J Adolesc Health. 15:1994;311-318.
20. Levine C. Children in HIV/AIDS clinical trials Still vulnerable after all these years. Law Med Health Care. 19:1991;231-237.
21. DuRant R.H., Cadenhead C., Pendergrast R.A., et al. Factors associated with the use of violence among urban black adolescents. Am J Public Health. 84:1994;612-617.
22. Rutter M. Psychosocial resilience and protective mechanisms. Am J Orthopsychiatry. 57:1987;316-331.
23. Resnick M.D., Bearman P.S., Blum R.W., et al. Protecting adolescents from harm Findings from the National Longitudinal Study of Adolescent Health. JAMA. 278:1997;823-832.
24. Rogers A.S., D'Angelo L., Futterman D. Guidelines for adolescent participation in research Current realities and possible resolutions. IRB. 16:1994;1-6.
25. A Decade of Denial Teens and AIDS in America. 1992;U.S. Government Printing Office, Washington, DC.
26. Levine C., Dubler N.N., Levine R.J. Building a new consensus Ethical principles and policies for clinical research on HIV/AIDS. IRB. 13:1991;1-17.
27. Grodin M.A., Alpert J.J. Children as participants in medical research. Pediatr Clin North Am. 35:1988;1389-1401.
28. Gardner W., Wilcox B.L. Political intervention in scientific peer review Research on adolescent sexual behavior. Am Psychol. 48:1993;972-983.
29. Mammel K.A., Kaplan D.W. Research consent by adolescent minors and institutional review boards. J Adolesc Health. 17:1995;322-329.
30. Sieber J.E., Stanley B. Ethical and professional dimensions of socially sensitive research. Am Psychol. 43:1988;49-55.
31. Janofsky J., Starfield B. Assessment of risk in research on children. J Pediatr. 89:1981;842-846.
32. Rogers A.S., Schwarz D.F., Weissman G., English A. Adolescent participation in clinical research Eleven sites, one common protocol, and Eleven IRBs. IRB. 21:1999;6-10.
33. Department of Health and Human Services, National Institutes of Health, Office for Protection from Research Risks. Code of Federal Regulations: Title 45-Public Welfare; Part 46: Protection of Human Subjects. November 13, 2001.
34. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: US Government Printing Office, DHEW Pub. No. (OS) 78-0012, 1978.
35. Code of Research Ethics A Position Paper of the Society for Adolescent Medicine. J Adolesc Health. 24:1999;277-282.
36. Bleyer WA, Tejeda H, Murphy SB, et al. National cancer clinical trials: Children have equal access; adolescents do not. J Adolesc Health 1997;366-73.
37. National Institutes of Health. NIH Policy and Guidelines On The Inclusion Of Children As Participants In Research Involving Human Subjects. March 6, 1998. Available at: http://grants1.nih.gov/grants/guide/notice-files/ not98-024.html. Accessed April 10, 2003.
38. Glantz L.H. The law of human experimentation with children. Grodin M.A., Glantz L.H. Children as Research Subjects Science, Ethics, and Law. 1994;103-130 Oxford University Press, New York.
39. Melton G.B. Children's rights Where are the children? Am J Orthopsychiatry. 52:1982;530-538.
40. Holder A.R. Legal issues in adolescent sexual health. Adolesc Med: STAR. 3:1992;257-268.
41. English A. Treating adolescents Legal and ethical considerations. Med Clin North Am. 74:1990;1097-1112.
42. English A., Matthews M., Palamountain C., et al. State Minor Consent Statutes A summary. 1995;National Center for Youth Law, San Francisco.
43. English A., Morreale M. A legal and policy framework for adolescent health care Past, present, and future. Houston J Health Law Policy. 1:2001;63-108.
44. Melton G.B. Ethical and legal issues in research and intervention. J Adolesc Health Care. 10:(3 Suppl):1989;36S-44S.
45. English A. Adolescent reproductive health services for adolescents: Critical legal issues. Obstet Gynecol Clin North Am 2000;27195-211.
46. Gans J. Policy Compendium on Confidential Health Services for Adolescents. 1993;American Medical Association National Coalition on Adolescent Health, Chicago.
47. Department of Health and Human Services. Standards for Privacy of Individually Identifiable Health Information; Final Rule. 65 Fed. Reg. 82462 (2000); 67 Fed. Reg. 53182 (2002) (to be codified at 45 CFR Parts 160 and 164).
48. Department of Health and Human Services. Protecting personal health information in research - Understanding the HIPAA Privacy Rule. Department of Health and Human Services. Washington, DC: Department of Health and Human Services, 2003.
49. Department of Health and Human Services. Standards for Privacy of Individually Identifiable Information; Final Rule, 67 Fed. Reg. 53267 (2002) (to be codified at 45 CFR 164.502(g)(3)).
50. Leikin S.L. An ethical issue in biomedical research The involvement of minors in informed and third party consent. Clin Res. 31:1983;34-40.
51. Weithorn L.A. Children's capacities to decide about participation in research. IRB. 5:1983;1-5.
52. Weithorn L.A., Scherer D.G. Children's involvement in research participation decisions Psychological considerations. Grodin M.A., Glanz L.H. Children as Research Subjects Science, Ethics, and Law. 1994;133-179 Oxford University Press, New York.
53. Melton G.B. Toward "personhood" for adolescents. Autonomy and privacy as values in public policy. Am Psychol. 38:1983;99-103.
54. Susman EJ, Dorn LD, Fletcher JC. Participation in biomedical research: The consent process as viewed by children, adolescents, young adults, and physicians. J Pediatr 1992;547-52.
55. Peterson A.C., Leffert N. Developmental issues influencing guidelines for adolescent health research. J Adolesc Health. 17:1995;298-305.
56. Thompson R.A. Vulnerability in research A developmental perspective on research risk. Child Dev. 61:1980;1-16.
57. Ethical and Policy Issues in Research Involving Human Participants, Volume I. Report and Recommendations of the National Bioethics Advisory Commission. 2001;Office of the President, Bethesda, MD.
58. Levine R.J. Adolescents as research subjects without permission of their parents or guardians Ethical considerations. J Adolesc Health. 17:1995;286-296.
59. Mastrionni A.C., Faden R., Federman D. Women and Health Research Ethical and Legal Issues of Including Women in Clinical Studies, Volume I. 1994;Institute of Medicine, National Academy Press, Washington.
60. Food and Drug Administration. The Pediatric Exclusionary Provision, January 2001 Status Report to the Congress (January 9, 2001). Website: http://www.fda.gov/cder/pediatric/reportcong01.pdf. Accessed April 10, 2003.
61. Food and Drug Administration. Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients; Final Rule. 21 CFR Parts 201, 312, 314, and 601. Website: http://www.fda.gov/ohrms/dockets/98fr/120298c.txt. Accessed April 10, 2003.
62. Shirkey H.C. Therapeutic orphans. J Pediatr. 72:1968;119-120.
63. Levine R.J. Institutional review boards A crisis in confidence. Ann Intern Med. 134:2001;161-163.
64. Melton G.B., Levine R.J., Koocher G.P., et al. Community consultation in socially sensitive research. Lessons from clinical trials of treatments for AIDS. Am Psychol. 43:1988;573-581.
65. Jenkins R., Parron D. Guidelines for adolescent health research Issues of race and class. J Adolesc Health. 17:1995;313-321.
66. Thomas S.B., Quinn S.C. The Tuskegee Syphilis study, 1932 to 1972 Implications HIV education and AIDS risk education programs in the black community. Am J Public Health. 81:1991;1498-1504.
67. Lederer S.E., Grodin M.A. Historical overview: Pediatric experimentation. Grodin M.A., Glanz L.H. Children as Research Subjects: Science, Ethics, and Law. 1994;3-25 Oxford University Press, New York.
68. Gans J.E., Brindis C.D. Choice of research setting in understanding adolescent health problems. J Adolesc Health. 17:1995;305-312.
69. 20 U.S.C. § 1232g; 34 C.F.R. Part 99.
70. 20 U.S.C. § 1232h; 34 C.F.R. Part 98.
71. U.S. Department of Education. Recent Changes Affecting FERPA & PPRA. October 28, 2002. Available at: http://www.ed.gov/offices/OII/fpca/pdf/ ht_102802.pdf. Accessed May 6, 2003.
72. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Report and Recommendations: Research Involving Children. Washington, DC: US Government Printing Office, DHEW Pub. No. (OS) 77-0004, 1977.
73. English A. Guidelines for adolescent health research Legal perspectives. J Adolesc Health. 17:1995;276-285.
74. Food and Drug Administration. Additional Safeguards for Children in Clinical Investigations of FDA-Regulated Products. 21 CFR Parts 50 and 56. Federal Register: April 24, 2001 (Volume 66, Number 79), Rules and Regulations, Pages 20589-600. Available at: http://www.fda.gov/OHRMS/DOCKETS/98fr/042401a. pdf. Accessed April 10, 2003.
75. National Human Research Protections Advisory Committee. Comment letter to the FDA on 45 CFR 46 408(c). August 13, 2001. Available at: http://ohrp.osophs.dhhs.gov/nhrpac/documents/fda.pdf. Accessed September 1, 2002.
76. English A, Morreale MC, Stinnett A, et al. State minor consent laws: A summary. Chapel Hill, NC: Center for Adolescent Health & the Law. (In press.).